BT
MRNA icon

Banque Transatlantique’s Moderna MRNA Stock Holding History

Banque Transatlantique’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$895K Buy
21,793
+3,716
+21% +$192K 0.02% 173
2026
Q1 		$916K Sell
18,077
-2,341
-11% -$109K 0.02% 138
2025
Q4 		$619K Sell
20,418
-5,463
-21% -$148K 0.02% 88
2025
Q3 		$677K Sell
25,881
-3,779
-13% -$105K 0.02% 89
2025
Q2 		$832K Sell
29,660
-4,545
-13% -$120K 0.02% 80
2025
Q1 		$968K Sell
34,205
-35,503
-51% -$1.26M 0.03% 82
2024
Q4 		$2.86M Buy
+69,708
New +$3.33M 0.07% 56

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Banque Transatlantique's MRNA Position: Q2 2026 in Review

Banque Transatlantique increased its Moderna (MRNA) stake by 21% in Q2 2026, buying an estimated $192K and bringing the position to 21,793 shares worth $895K. The position accounts for 0.02% of the portfolio, ranked #173.

Banque Transatlantique first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.86M in Q4 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Banque Transatlantique held 21,793 shares of Moderna worth $895K as of Q2 2026.
  • Banque Transatlantique bought 3,716 Moderna shares in Q2 2026, an estimated $192K.
  • Moderna made up 0.02% of Banque Transatlantique's portfolio in Q2 2026, its #173 holding.
  • Banque Transatlantique first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Moderna position peaked at $2.86M in Q4 2024.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.